Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer

Current Opinion in Oncology

Volumn 10, Issue 3, 1998, Pages 213-218

  Adelstein, David J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; HYDROXYUREA; METHOTREXATE; MITOMYCIN C;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MORBIDITY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

EID: 0031804343     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199805000-00007     Document Type: Article

References (40)

1. Adelstein DJ, Tan EH, Lavertu P: Treatment of head and neck cancer: the role of chemotherapy. Crit Rev Oncol Hematol 1996, 24:97-116.
2. Brockstein BE, Vokes EE: Chemoradiotherapy for head and neck • cancer. Updates: Principles Pract Oncol 1996, 10:1-19. This is a recent and comprehensive review of the use of chemotherapy and radiation together in the management of head and neck cancer. The University of Chicago phase II experience is summarized.
3. Lo TCM, Wiley AL Jr, Ansfield FJ, Brandenburg JH, Davis HL Jr, Gollin FF, Johnson RO, Ramirez G, Vermund H: Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study. Am J Roentgenol 1976, 126:229-235.
4. Sanchiz F, Milla A, Torner J, Bonet F, Artola N, Carren̄o L, Moya LM, Riera D, Ripol S, Cirera L: Single fraction per day versus two fractions per day versus radiochemotherapy In the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 1990, 19:1347-1350.
5. Browman GP, Cripps C, Hodson DI, Eapen L, Sathya J, Levine MN: Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 1994, 12:2648-2653.
6. Gupta NK, Pointon RCS, Wilkinson PM: A randomized clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clin Radiol 1987, 38:575-581.
7. Shanta V, Krishnamurthi S: Combined bleomycin and radiotherapy in oral cancer. Clin Radiol 1980, 31:617-620.
8. Vermund H, Kaalhus O, Winther F, Trausjø J, Thorud E, Harang R: Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: a phase III clinical trial. Int J Radiat Oncol Biol Phys 1985, 11:1877-1886.
9. Fu KK, Phillips TL, Silverberg IJ, Jacobs C, Goffinet DR, Chun C, Friedman MA, Kohler M, McWhirter K, Carter SK: Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987, 5:1410-1418.
10. Eschwege F, Sancho-Garnier H, Gerard JP, Madelain M, DeSaulty A, Jortay A, Cachin Y: Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the European Organization for Research and Treatment of Cancer. NCI Monogr 1988, 6:275-278.
11. Haffty BG, Son YH, Papac R, Sasaki CT, Weissberg JB, Fischer D, •• Rockwell S, Sartorelli AC, Fischer JJ: Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale mitomycin randomized trials. J Clin Oncol 1997, 15:268-276. This is a recent update of the Yale mitomycin C randomized trials conducted between 1980 and 1992. Most patients were treated postoperatively, and long term follow-up is presented. No overall survival benefit was observed, although other endpoints statistically favored concurrent chemoradiotherapy.
12. Weissberg JB, Son YH, Papac RJ, Sasaki C, Fischer DB, Lawrence R, Rockwell S, Sartorelli AC, Fischer JJ: Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys 1989, 17:3-9.
13. Stefani S, Chung TS: Hydroxyurea and radiotherapy in head and neck cancer: long term results of a double blind randomized prospective study [abstract]. Int J Radiat Oncol Biol Phys 1980, 6:1398.
14. Haselow RE, Adams GS, Oken MM, Goudsmit A, Lerner HJ, Marsh JC: Cis-platinum (DDP) with radiation therapy (RT) for locally advanced unresectable head and neck cancer [abstract]. Proc Am Soc Clin Oncol 1983, 2:160.
15. Haselow RE, Warshaw MG, Oken MM, Adams GL, Aughey JL, Cooper JS, Schuller DE, Jacobs CD: Radiation alone versus radiation with weekly low dose cis-platinum in unresectable cancer of the head and neck. Head and Neck Cancer, vol II. Edited by Fee WE Jr, Goepfert H, Johns ME, et al. Philadelphia: JB Lippincott; 1990:279-281.
16. Gabriele P, Tessa M, Ragona R, Rampino M, Ruo Redda MG, Beltramo G, Airoldi M, Rotta P, Melano A, Moro G, et al.: An interim analysis of phase III study on radiotherapy (RT) versus RT plus carboplatin (CBDCA) in inoperable stage III-IV head and neck (H&N) carcinoma [abstract]. In Proceedings of the Fourth International Conference on Head and Neck Cancer. Toronto; 1996:116.
17. Bachaud J-M, Cohen-Jonathan E, Alzieu C, David J-M, Serrano E, Daly-•• Schveitzer N: Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys 1996, 36:999-1004. This is the final report of a phase III trial comparing postoperative radiation with postoperative radiation and weekly cisplatin. Locoregional control and survival were improved in the concurrent treatment group.
18. Weissler MC, Melin S, Sailer SL, Qaqish BF, Rosenman JG, Pillsbury HC III: Simultaneous chemoradiation in the treatment of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1992, 118:806-810.
19. Keane TJ, Cummings BJ, O'Sullivan B, Payne D, Rawlinson E, MacKenzie R, Danjoux C, Hodson I: A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys 1993, 25:613-618.
20. Smid L, Lesnicar H, Zakotnik B, Soba E, Budihna M, Furlan L, Zargi M, Rudolf Z: Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer: preliminary report. Int J Radiat Oncol Biol Phys 1995, 32:769-775.
21. Wustro TPU, Wendt TG, Grabenbauer G, Aydin H, Thiel H-J, Willich N, Schalhorn A: Randomized phase III study for simultaneous radiopolychemotherapy in head and neck cancer [abstract]. Proceedings of the Fourth International Conference on Head and Neck Cancer. Toronto; 1996:233.
22. Brizel DM, Albers MA, Fisher SR, Scher RL, Richtsmeier WJ, Clough R, George SL, Prosnitz LR: A phase III trial of hyperfractionated irradiation ± concurrent chemotherapy for locally advanced carcinoma of the head and neck: superiority of combined modality treatment [abstract]. Proc Am Soc Clin Oncol 1997, 16:384a.
23. Adelstein DJ, Saxton JP, Lavertu P, Tuason L, Wood BG, Wanamaker JR. •• Eliachar I, Strome M, Van Kirk MA: A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Week 1997, 19:567-575. This is a preliminary report of the author's randomized trial comparing multiagent chemoradiotherapy with radiation alone. Surgical resection was an integral part of management in patients with residual or recurrent disease after nonoperative treatment. Relapse-free survival, likelihood of distant metastases, and organ preservation were improved in the concurrent treatment group.
24. Lavertu P, Adelstein DJ, Saxton JP, Secic M, Wanamaker JR, Eliachar I, Wood BG, Strome M: Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 1997, 19:559-566.
25. Adelstein DJ, Sharan VM, Earle AS, Shah AC, Vlastou C, Haria CD, Damm C, Carter SG, Hines JD: Long-term follow-up of a prospective randomized trial comparing simultaneous and sequential chemoradiotherapy for squamous cell head and neck cancer. In Adjuvant Therapy of Cancer VII. Edited by Salmon SE. Philadelphia: JB Lippincott; 1993:82-91.
26. Taylor SG, Murthy AK, Vannetzel J-M, Colin P, Dray M, Calcarelli DD, Shott S, Vokes E, Showel JL, Hutchinson JC, et al.: Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 1994, 12:385-395.
27. Looney WB, Hopkins HA: Rationale for different chemotherapeutic and radiation therapy strategies in cancer management Cancer 1991, 67:1471-1483.
28. SECOG participants: A randomized trial of combined multidrug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol 1986, 12:289-295.
29. Merlano M, Corvȯ R, Margarino G, Benasso M, Rosso R, Sertoli MR, Cavallari M, Scala M, Guenzi M, Siragusa A, et al.: Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. Cancer 1991, 67:915-921.
30. Merlano M, Benasso M, Corvȯ R, Rosso R, Vitale V, Blengio F, Numico G, •• Margarine G, Bonelli L, Santi L: Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1996, 88:583-589. This is a recent update of a trial comparing rapidly alternating radiation and chemotherapy with 5-fluorouracil and cisplatin to radiation therapy alone. At 5 years, the rapidly alternating chemoradiotherapy was superior for all measured endpoints.
31. Marcial VA, Pajak TF, Mohiuddin M, Cooper JS, Al-Sarraf M, Mowry PA. Curran W, Crissman J, Rodriguez M, Vélez-Garcia E: Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Cancer 1990, 66:1861-1868.
32. Al-Sarraf M, LeBlanc M, Giri PGS, Fu K, Cooper J, Vuong T, Forastiere A. Adams G, Sakr W, Schuller D, Ensley J: Superiority of chemoradiotherapy (CT-RT) vs radiotherapy (RT) in patients (PTS) with locally advanced nasopharyngeal cancer (NPC): preliminary results of Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) randomized study [abstract]. Proc Am Soc Clin Oncol 1996, 15:313.
33. Tishler RB, Busse PM, Norris CM, Rossi R, Poulin M, Thornhill L, Costello R, Peters ES, Colevas AD, Posner MR: Concomitant paclitaxel and once-daily radiotherapy in the treatment of head and neck cancer [abstract]. Proc Am Soc Clin Oncol 1997, 16:386a.
34. Flood WA, Lee DJ, Trotti A, DeConti R, Endicott J, Spencer S, Wheeler R, Taylor S IV, Forastiere AA: A phase I study of weekly paclitaxel and cisplatin concurrent with postoperative radiation therapy for treatment of high-risk patients with squamous cell cancer of the head and neck [abstract]. Proc Am Soc Clin Oncol 1996, 15:314.
35. Bensadoun RJ, Dassonville O, Milano G, Pignol JP, Courdi A, Marcy PY, Bourdin S, Prevost B, Chauvel P, Demard F, Schneider M: Treatment of locally advanced unresectable pharyngeal carcinoma with continuous twice-a-day radiotherapy and concomitant CDDP-5FU chemotherapy (BiRCF): final results of a French multicentric phase II study (FNCLCC) [abstract]. Proceedings of the Fourth International Conference on Head and Neck Cancer. Toronto; 1996:102.
36. Abitbol AA, Sridhar KA, Lewin AA, Schwade JG, Raub W, Wolfson A, Gonzalez-Angulo C, Adessa A, Goodwin WJ, Markoe AM: Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin and mitomycin-C (± granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma. Cancer 1997, 80:266-276.
37. Kies MS, Haraf DJ, Mittal B, Stenson K, Athanasiadis I, Kozloff M, Miller M, Pelzer H, Wenig B, Weichselbaum R, Vokes EE: Intensive combined therapy with C-DDP, 5-FU, hydroxyurea, and BID radiation (C-FHX) for stage IV squamous cancer (SCC) of the head and neck [abstract]. Proc Am Soc Clin Oncol 1996, 15:314.
38. Robbins KT, Kumar P, Regine WF, Wong FSH, Weir AB, Flick P, Kun LE, • Palmer R, Murry T, Fontanesi J, et al.: Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys 1997, 38:263-271. This is a report of a large phase II trial using intra-arterial high-dose cisplatin and concurrent radiation therapy. Intriguing success in achieving locoregional control was observed. Phase III study is necessary.
39. Munro AJ; An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995, 71:83-91.
40. El-Sayed S, Nelson N: Adjuvant and adjunctive chemotherapy in the • management of squamous cell carcinoma of the head and neck region: a meta-analysis of prospective and randomized trials. J Clin Oncol 1996, 14:838-847. This is a recent meta-analysis demonstrating a significant survival improvement in patients treated with simultaneous chemotherapy and local management. The addition of chemotherapy also was noted to significantly increase the treatment morbidity.